{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:40:19Z","timestamp":1760240419081,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annalsofvascularsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.avsg.2019.09.032","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T12:09:44Z","timestamp":1571400584000},"page":"188-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Midterm Outcomes of Drug-Coated Balloon Angioplasty in Femoropopliteal Lesions in a Daily Practice Cohort"],"prefix":"10.1016","volume":"64","author":[{"given":"Michael","family":"Nugteren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Sern\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart","family":"Verhoeven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Koning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"van den Haak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Scholtes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan-Willem","family":"Hinnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2019.09.032_bib1","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","article-title":"2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the european society for vascular surgery (ESVS)","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.avsg.2019.09.032_bib2","first-page":"787","article-title":"Quantitative assessment of the conformational change in the femoropopliteal artery with leg movement","volume":"74","author":"Klein","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2019.09.032_bib3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jacc.2004.11.026","article-title":"Prevalence and clinical impact of stent fractures after femoropopliteal stenting","volume":"45","author":"Scheinert","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2019.09.032_bib4","doi-asserted-by":"crossref","first-page":"e005891","DOI":"10.1161\/CIRCINTERVENTIONS.117.005891","article-title":"Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN.PACT SFA randomized trial","volume":"11","author":"Schneider","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2019.09.032_bib5","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jvs.2016.05.084","article-title":"Drug-eluting balloon angioplasty versus uncoated balloon angioplasty in patients with femoropopliteal arterial occlusive disease","volume":"64","author":"Jongsma","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2019.09.032_bib6","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/CIRCULATIONAHA.110.936922","article-title":"Drug-coated balloons for the prevention of vascular restenosis","volume":"121","author":"Gray","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2019.09.032_bib7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/1526602817745565","article-title":"Drug-coated balloon vs standard percutaneous transluminal angioplasty for the treatment of Atherosclerotic lesions in the superficial femoral and Proximal popliteal arteries: one-year results of the MDT-2113 SFA Japan randomized trial","volume":"25","author":"Iida","year":"2018","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2019.09.032_bib8","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jcin.2013.01.128","article-title":"2-Year results of paclitaxel-eluting balloons for femoropopliteal artery disease","volume":"6","author":"Micari","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2019.09.032_bib9","first-page":"73","article-title":"Comparing SFA device trials","author":"Jaff","year":"2013","journal-title":"Endovascular Today"},{"key":"10.1016\/j.avsg.2019.09.032_bib10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease 12-month results from the IN.PACT SFA randomized Trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2019.09.032_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.avsg.2018.06.015","article-title":"Risk factors for restenosis after drug-coated balloon angioplasty for complex femoropopliteal arterial occlusive disease","volume":"55","author":"Roh","year":"2019","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2019.09.032_bib12","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jcin.2018.02.019","article-title":"Drug-coated balloon treatment of femoropopliteal lesions for patients with intermittent claudication and ischemic rest Pain: 2-year results from the IN.PACT Global study","volume":"11","author":"Micari","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2019.09.032_bib13","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2015.09.063","article-title":"Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA","volume":"66","author":"Laird","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2019.09.032_bib14","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jcin.2015.12.267","article-title":"Drug-coated balloons for complex femoropopliteal lesions 2-year results of a Real-World Registry","volume":"9","author":"Schmidt","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2019.09.032_bib15","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCINTERVENTIONS.111.967794","article-title":"Do pharmacokinetics explain persistent restenosis inhibition by a single dose of paclitaxel?","volume":"5","author":"Speck","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2019.09.032_bib16","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","article-title":"Durable clinical Effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial","volume":"133","author":"Dake","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2019.09.032_bib17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jacc.2011.09.036","article-title":"Classification and clinical impact of restenosis after femoropopliteal stenting","volume":"59","author":"Tosaka","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2019.09.032_bib18","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.jcin.2017.06.018","article-title":"Drug-coated balloon treatment for femoropopliteal artery disease: the IN.PACT Global study De novo in-stent restenosis imaging cohort","volume":"10","author":"Brodmann","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2019.09.032_bib19","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1161\/CIRCULATIONAHA.115.017364","article-title":"Drug-coated balloon versus standard balloon for superficial femoral artery in-stent restenosis: the randomized Femoral Artery In-Stent Restenosis (FAIR) trial","volume":"132","author":"Krankenberg","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2019.09.032_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1583\/13-4420R.1","article-title":"Paclitaxel-eluting balloon vs. Standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE-ISR study","volume":"21","author":"Liistro","year":"2014","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2019.09.032_bib21","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcin.2013.11.020","article-title":"Drug-eluting balloons for the treatment of the superficial femoral artery in-stent restenosis: 2-year follow-up","volume":"7","author":"Virga","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2019.09.032_bib22","doi-asserted-by":"crossref","first-page":"e005654","DOI":"10.1161\/CIRCINTERVENTIONS.117.005654","article-title":"Drug-coated balloon treatment for femoropopliteal artery disease","volume":"11","author":"Scheinert","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2019.09.032_bib23","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jcin.2017.01.028","article-title":"2-year results of paclitaxel-coated balloons for long femoropopliteal artery disease: evidence from the SFA-long study","volume":"10","author":"Micari","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2019.09.032_bib24","doi-asserted-by":"crossref","first-page":"e011245","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.avsg.2019.09.032_bib25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2018.11.039","article-title":"Drug-eluting stent versus drug-coated balloon revascularization in patients with femoropopliteal arterial disease","volume":"73","author":"Bausback","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2019.09.032_bib26","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.jvs.2013.11.063","article-title":"Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes","volume":"59","author":"Mueller","year":"2014","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2019.09.032_bib27","first-page":"679","article-title":"The Zilver\u00ae PTX\u00ae single Arm study: 12-month results from the TASC C\/D lesion subgroup","volume":"54","author":"Bosiers","year":"2013","journal-title":"J Cardiovasc Surg"},{"key":"10.1016\/j.avsg.2019.09.032_bib28","first-page":"229","article-title":"Effectiveness of Zilver PTX eluting stent in TASC C\/D lesions and restenosis","volume":"55","author":"Leopardi","year":"2014","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.avsg.2019.09.032_bib29","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.carrev.2015.09.001","article-title":"Clinical outcomes of endovascular treatment of TASC-II C and D femoropopliteal lesions with the Viabahn endoprosthesis","volume":"16","author":"Mohr","year":"2015","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.avsg.2019.09.032_bib30","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1583\/14-4790R.1","article-title":"Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial","volume":"21","author":"Zeller","year":"2014","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2019.09.032_bib31","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jacc.2013.05.079","article-title":"Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial","volume":"62","author":"Lammer","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2019.09.032_bib32","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.jvs.2010.11.092","article-title":"Assessment of functional status and quality of life in claudication","volume":"53","author":"Mays","year":"2011","journal-title":"J Vasc Surg"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509619308751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509619308751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:57:08Z","timestamp":1760187428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509619308751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":32,"alternative-id":["S0890509619308751"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2019.09.032","relation":{},"ISSN":["0890-5096"],"issn-type":[{"type":"print","value":"0890-5096"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Midterm Outcomes of Drug-Coated Balloon Angioplasty in Femoropopliteal Lesions in a Daily Practice Cohort","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2019.09.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}